Last update:

3D-printed brain sensors may unlock personalized neural monitoring

Soft electrodes designed to perfectly match a person's brain surface may help advance neural interfaces for neurodegenerative disease monitoring and treatment, according to a new study led by Penn State researchers. Neural ...

Sex differences in brain gene activity could explain why some disorders affect men and women differently

The physical differences between men and women are all too obvious, but the biological divide goes right down to the cellular level in the brain, according to a new study published in the journal Science.

Medical research news

Cutting calories to slow aging—without compromising health

Restricting calorie intake in species such as mice, rhesus monkeys, and fruit flies has been shown to extend their lifespans. In some cases, these animals not only live longer, but are also free of disease. But when pushed ...

Large trial shows bone healing 'superpower' in children

Broken wrists are among the most common injuries in children, accounting for about half of children's fractures. Severely displaced distal radial fractures, where the bones move out of place, are often routinely treated with ...

Fructose emerges as a key driver of metabolic disease

A new report, published in Nature Metabolism, is shedding light on the distinct and underappreciated role of fructose in driving disease, separate from its role as a simple source of calories.

How an overactive immune system can drive cancer

The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system instead attacks the body's own cells. Conditions such as systemic lupus erythematosus (lupus) and ...

Why anti-cancer drugs do not always live up to expectations

For more than a decade, a class of drugs called BET inhibitors has been tested in cancer trials with high expectations. The biology looked promising. Many cancers depend on oncogenes that "Bromo- and Extra-Terminal domain" ...

Without the right tests, the best medicines make no difference

A new analysis from UC San Francisco argues that diagnostics—medical tests that match patients to the appropriate treatment—are being overlooked both in the United States and around the world. This is slowing progress against ...